The rate of maternal mortality related to cardiovascular ... this is happening is because heart disease and hypertension are becoming more and more prevalent, as are the conditions that are connected ...
Findings from the American College of Cardiology 2025 Annual Scientific Session show oral semaglutide reduces the risk of ...
Use of antidepressants for 6 or more years is linked to an increased risk for sudden cardiac death, but it’s unclear if the ...
News-Medical.Net on MSN4d
Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral ...
One study found that Black women were 3 times more likely to die of maternal deaths due to cardiovascular disease than White ...
In the SOUL trial, Rybelsus produced a 14% risk reduction of major adverse cardiovascular events in patients with type 2 ...
Wegovy was also associated with a lower risk of hospitalization for heart failure, cardiovascular-related death, and ...
Recent study shows oral semaglutide reduces cardiovascular risk in type 2 diabetes patients, enhancing diabetes and heart ...
The Economic Survey 2024-25 reveals an expected increase in Goa's population to 15.96 lakh by 2025 but highlights worrying ...
Refined grains, potatoes and sugary drinks can pack on extra pounds and cause blood sugar to spike, researchers noted. As a ...
9d
March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback